Pharmaceutical Product Development (United States)

35.1k citations
923 papers ·

Impact in

Papers in

Pharmaceutical Product Development (United States)

816 papers receiving 30.0k citations

Peers

Pharmaceutical Product Development (United States)
Comparison fields: 5 of 221
  • Pharmaceutical Science 1.2k
  • Infectious Diseases 3.2k
  • Geriatrics and Gerontology 563
  • Molecular Biology 11.2k
  • Radiology, Nuclear Medicine and Imaging 3.4k
Replace Nanotherapeutics (United States) with:
Nanotherapeutics (United States) United States
Ortho Clinical Diagnostics (United States) United States
National Institute of General Medical Sciences United States
Deerfield (United States) United States
American Society of Clinical Oncology United States
Wolters Kluwer Health United States
United States Pharmacopeial Convention United States
Clinical Research Management United States
Nashville VA Medical Center United States
Piedmont Cancer Institute United States
Pharmaceutical Product Development (United States) relative to Nanotherapeutics (United States) United States Nanotherapeutics (United States)'s profile →
Citations per field
00.5×2×3×4×4.7×
Nanotherapeutics (United States) · 1×
Citations per year

Countries citing scholars working at Pharmaceutical Product Development (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Pharmaceutical Product Development (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Pharmaceutical Product Development (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pharmaceutical Product Development (United States) more than expected).

Fields of papers published by authors at Pharmaceutical Product Development (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Pharmaceutical Product Development (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Pharmaceutical Product Development (United States) at the time of their publication.

About Pharmaceutical Product Development (United States)

In recent decades, authors affiliated with Pharmaceutical Product Development (United States) have published 923 papers, which have received a total of 35.1k indexed citations . Scholars at this organization have produced 40 papers in Pharmaceutical Science, 88 papers in Immunology, 77 papers in Infectious Diseases, 234 papers in Molecular Biology and 46 papers in Psychiatry and Mental health on the topics of Protein purification and stability (79 papers), Biosimilars and Bioanalytical Methods (57 papers), Genetic and Kidney Cyst Diseases (57 papers), Monoclonal and Polyclonal Antibodies Research (46 papers), Tuberculosis Research and Epidemiology (36 papers), Drug Solubulity and Delivery Systems (31 papers), Viral Infectious Diseases and Gene Expression in Insects (28 papers) and Electrolyte and hormonal disorders (24 papers). Their work is cited by papers focused on Pharmaceutical Science (1.2k citations), Infectious Diseases (3.2k citations), Geriatrics and Gerontology (563 citations), Molecular Biology (11.2k citations) and Radiology, Nuclear Medicine and Imaging (3.4k citations). Authors at Pharmaceutical Product Development (United States) collaborate with scholars in United States, United Kingdom and Germany and have published in prestigious journals including Bioanalysis, Journal of Pharmaceutical Sciences, The Journal of Clinical Pharmacology, Pharmaceutical Research and The AAPS Journal. Some of Pharmaceutical Product Development (United States)'s most productive authors include Steven J. Shire, Frank S. Czerwiec, Robert S. Wallis, Carole W. Cranor, Dale B. Christensen, John F. Ouyang, Vicente E. Torres, Alla Danilkovitch‐Miagkova, Arlene B. Chapman and Holly B. Krasa.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact